QTTB
QTTB
NASDAQ · Biotechnology

Q32 Bio Inc

$4.24
+0.37 (+9.56%)
As of Feb 8, 2:18 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 8.10M 7.51M 6.99M
Net Income -2,253,266 -2,377,750 -1,909,981
EPS
Profit Margin -27.8% -31.6% -27.3%
Rev Growth +18.0% -0.1% +13.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 26.39M 25.22M 27.43M
Total Equity 33.72M 33.32M 32.74M
D/E Ratio 0.78 0.76 0.84
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -3,375,106 -3,186,219 -2,905,098
Free Cash Flow -1,035,116 -1,228,536 -1,335,718